CORD-19:f1fd5f33dcbe0aae1ce2efb7b7d22eafb4247f02 / 21432-21674 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T118","span":{"begin":0,"end":242},"obj":"Sentence"}],"text":"Further, macrolides and ketolides that are prescribed for M. pneumoniae and C. pneumoniae infections have antiinflammatory properties, making it difficult to determine if atypical bacteria are playing a role in asthma exacerbations (54, 55) ."}

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T118","span":{"begin":0,"end":242},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Further, macrolides and ketolides that are prescribed for M. pneumoniae and C. pneumoniae infections have antiinflammatory properties, making it difficult to determine if atypical bacteria are playing a role in asthma exacerbations (54, 55) ."}

{"project":"Epistemic_Statements","denotations":[{"id":"T61","span":{"begin":0,"end":242},"obj":"Epistemic_statement"}],"text":"Further, macrolides and ketolides that are prescribed for M. pneumoniae and C. pneumoniae infections have antiinflammatory properties, making it difficult to determine if atypical bacteria are playing a role in asthma exacerbations (54, 55) ."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T134","span":{"begin":61,"end":71},"obj":"Phenotype"},{"id":"T135","span":{"begin":79,"end":89},"obj":"Phenotype"},{"id":"T136","span":{"begin":211,"end":217},"obj":"Phenotype"}],"attributes":[{"id":"A134","pred":"hp_id","subj":"T134","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A135","pred":"hp_id","subj":"T135","obj":"http://purl.obolibrary.org/obo/HP_0002090"},{"id":"A136","pred":"hp_id","subj":"T136","obj":"http://purl.obolibrary.org/obo/HP_0002099"}],"text":"Further, macrolides and ketolides that are prescribed for M. pneumoniae and C. pneumoniae infections have antiinflammatory properties, making it difficult to determine if atypical bacteria are playing a role in asthma exacerbations (54, 55) ."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T240","span":{"begin":61,"end":71},"obj":"Disease"},{"id":"T241","span":{"begin":79,"end":89},"obj":"Disease"},{"id":"T242","span":{"begin":90,"end":100},"obj":"Disease"},{"id":"T243","span":{"begin":211,"end":217},"obj":"Disease"},{"id":"T78416","span":{"begin":61,"end":71},"obj":"Disease"},{"id":"T3984","span":{"begin":79,"end":89},"obj":"Disease"},{"id":"T45129","span":{"begin":90,"end":100},"obj":"Disease"},{"id":"T16524","span":{"begin":211,"end":217},"obj":"Disease"}],"attributes":[{"id":"A240","pred":"mondo_id","subj":"T240","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A241","pred":"mondo_id","subj":"T241","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A242","pred":"mondo_id","subj":"T242","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A243","pred":"mondo_id","subj":"T243","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"},{"id":"A23216","pred":"mondo_id","subj":"T78416","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A53327","pred":"mondo_id","subj":"T3984","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"},{"id":"A27239","pred":"mondo_id","subj":"T45129","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A60683","pred":"mondo_id","subj":"T16524","obj":"http://purl.obolibrary.org/obo/MONDO_0004979"}],"text":"Further, macrolides and ketolides that are prescribed for M. pneumoniae and C. pneumoniae infections have antiinflammatory properties, making it difficult to determine if atypical bacteria are playing a role in asthma exacerbations (54, 55) ."}